Association between accelerometer-measured light-intensity physical activity and tumor regression for male patients with esophageal cancer receiving neoadjuvant therapy: a retrospective cohort study
This study demonstrated that LIPA during NAC has a potential of promoting tumor regression with a cutoff value of 156.5 min/day. Further clinical research is required to determine the prognostic benefits of LIPA in patients receiving NAC.
Authors
- Toshifumi Ozaki (ORCID: https://orcid.org/0000-0003-1732-9307)
- Masashi Kanai (ORCID: https://orcid.org/0000-0002-0362-405X)
- Michiaki Hamada (ORCID: https://orcid.org/0000-0001-9466-1034)
- Toshiyoshi Fujiwara (ORCID: https://orcid.org/0000-0002-5377-6051)
- Kazuhiro Noma (ORCID: https://orcid.org/0000-0002-5584-3908)
- Masanori Konuma
- Tomohiro Ikeda (ORCID: https://orcid.org/0000-0001-5350-944X)
- Naoaki Maeda
- Shunsuke Tanabe (ORCID: https://orcid.org/0000-0002-4234-4309)
- Takayoshi Kawabata
Institutions
- Kanazawa University (JP)
- Okayama University (JP)
- Okayama University Hospital (JP)
Publication Details
- Journal
- Esophagus
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1007/s10388-025-01108-9
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Okayama University
- Japan Society for the Promotion of Science